Patents by Inventor Christopher E. Lawrence

Christopher E. Lawrence has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF TREATMENT OF TH2-MEDIATED CONDITIONS USING OPTIMIZED ANTI-CD30 ANTIBODIES
    Publication number: 20080206242
    Abstract: A method of treating Th2-mediated conditions, e.g., atopic conditions, e.g., atopic asthma and/or atopic dermatitis, using effective amount of an antibody that targets CD30, where the antibody has at least one modification relative to a parent antibody and the antibody binds with altered affinity to an Fc?R or alters effector function as compared to the parent antibody.
    Type: Application
    Filed: February 1, 2008
    Publication date: August 28, 2008
    Applicant: Xencor, Inc.
    Inventors: Christopher E. Lawrence, Philip W. Hammond